These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15085683)

  • 1. Pneumococcal vaccine: to vaccinate or to revaccinate--that is the question.
    Uiterwyk SH
    Med Health R I; 2004 Mar; 87(3):68-71. PubMed ID: 15085683
    [No Abstract]   [Full Text] [Related]  

  • 2. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on recommended use of pneumococcal conjugate vaccine.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2002 Jan; 28(ACS-2):1-32. PubMed ID: 12728645
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is pneumococcal conjugate vaccine needed?].
    Nuorti P
    Duodecim; 2002; 118(1):77-9. PubMed ID: 12229003
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of pneumococcal vaccine to standard immunisation programmes in Europe: what are we waiting for?
    Heininger U
    Eur J Pediatr; 2002 Dec; 161 Suppl 2():S125-6. PubMed ID: 12494257
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccine policy decisions: tension between science, cost-effectiveness and consensus?
    Zimmerman RK; Jackson RE
    Am Fam Physician; 2001 May; 63(10):1919, 1923. PubMed ID: 11388708
    [No Abstract]   [Full Text] [Related]  

  • 7. Pneumococcal disease and asplenia: the importance of vaccination.
    Clarke SC; Christie P; Edwards GF
    Health Bull (Edinb); 2001 Jan; 59(1):49-52. PubMed ID: 12811911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the costs and effects of a universal infant immunization program using conjugated pneumococcal vaccine in British Columbia.
    Moore D; Bigham M; Patrick D
    Can Commun Dis Rep; 2003 Jun; 29(11):97-104. PubMed ID: 12794969
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention with power. Breaking through barriers to pneumococcal vaccination.
    Miller T; Bishop J; Ruess L
    Adv Nurse Pract; 2008 Sep; 16(9):61-3. PubMed ID: 19999035
    [No Abstract]   [Full Text] [Related]  

  • 10. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.
    Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pneumococcal vaccine is clinically effective].
    Konradsen HB
    Ugeskr Laeger; 2001 Nov; 163(48):6771-4. PubMed ID: 11768910
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical characteristics of a novel 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine candidate (PHiD-CV). Introduction.
    Dagan R; Frasch C
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S63-5. PubMed ID: 19325448
    [No Abstract]   [Full Text] [Related]  

  • 13. Declining invasive pneumococcal disease in the U.S. elderly.
    McBean AM; Park YT; Caldwell D; Yu X
    Vaccine; 2005 Dec; 23(48-49):5641-5. PubMed ID: 16111788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
    Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.
    Adam D; Fehnle K
    Vaccine; 2008 Nov; 26(47):5944-51. PubMed ID: 18801402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal vaccine recommendations.
    Alper BS
    Am Fam Physician; 2000 Dec; 62(12):2588-9. PubMed ID: 11142467
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccines for other neonatal infections: pneumococcal disease: a major global health problem of young children.
    Richmond P
    Expert Rev Vaccines; 2004 Aug; 3(4):379-82. PubMed ID: 15270639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens.
    Mahon BE; Hsu K; Karumuri S; Kaplan SL; Mason EO; Pelton SI; ;
    Vaccine; 2006 Mar; 24(14):2514-20. PubMed ID: 16417951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pneumococcal polysaccharide vaccine on nonbacteremic pneumococcal pneumonia.
    Weiser JN; Austrian R
    Clin Infect Dis; 2007 Apr; 44(8):1139-40; author reply 1140-1. PubMed ID: 17366469
    [No Abstract]   [Full Text] [Related]  

  • 20. Pneumococcal vaccines WHO position paper - 2012 - recommendations.
    WHO Publication
    Vaccine; 2012 Jul; 30(32):4717-8. PubMed ID: 22621828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.